The case of amniotic fluid embolism successfully cured by multidisciplinary treatment

The authors present the clinical case as an example of a possible way to reduce maternal mortality from amniotic fluid embolism, timely diagnosis and treatment in order to save the mother's life.
The study describes a rare clinical case of amniotic fluid embolism, successfully cured with the help of multi-disciplinary treatment, which was treated at the RSE at the Regional Perinatal Center No. 1 (Turkestan region, Kazakhstan) in 2024.
Additional examinations were carried out in a timely manner: electrocardiograms, echocardiography, chest X-ray, specialist consultations: a therapist, an optometrist, a neurologist, a cardiologist. A multidisciplinary consultation with narrow specialists was held in a timely manner and, according to the recommendations of consultants; a correction in appointments was carried out. The medical team and anesthesiologists played a big role in saving the mother's life.
The presented clinical case shows that obstetricians, gynecologists, and intensive care specialists should pay attention to assessing the presence of predisposing factors for the development of EOV in each individual.

1. Benson M. D. Current concepts of immunology and diagnosis in amniotic fluid embolism /Clin. Dev. Immunol. – 2012. – V. 201. – 946576.

2. Clark S. L. Amniotic fluid embolism //Obstet. Gynecol. – 2014. – V. 123. – P. 337-348.

3. Driessen M. Postpartum hemorrhage resulting from uterine atony after vaginal delivery: factors associated with severity /M. Driessen, M. H. Bouvier-Colle, C. Dupont //Obstet. Gynecol. – 2011. – V. 117. – P. 21-31.

4. Hasegawa J. Current status of pregnancyrelated maternal mortality in Japan: a report from the maternal death exploratory committee in Japan /J. Hasegawa, A. Sekizawa, H. Tanaka //BMJ Open. – 2016. – V. 6. – P. 1-8.

5. Kanayama N. Amniotic fluid embolism: pathophysiology and new strategies for management /N. Kanayama, N. Tamura //J. Obstet. Gynaecol. Res. – 2014. – V. 40. – P. 1507-1517.

6. Kanayama N. Maternal death analysis from the Japanese autopsy registry for recent 16 years: significance of amniotic fluid embolism /N. Kanayama, J. Inori, H. Ishibashi-Ueda //J. Obstet. Gynaecol. Res. – 2011. – V. 37. – P. 58-63.

7. Knight M. Amniotic fluid embolism incidence, risk factors and outcomes: a review and recommendations /M. Knight, C. Berg, P. Brocklehurst //BMC Pregnancy Childbirth. – 2012. – V. 12. – P. 7.

8. Kobayashi T. Obstetrical disseminated intravascular coagulation score //J. Obstet. Gynaecol. Res. – 2014. – V. 40 (6). – P. 1500-1506.

9. Kramer M. S. Amniotic-fluid embolism and medical induction of labour: a retrospective, population-based cohort study /M. S. Kramer, J. Rouleau, T. F. Baskett //Lancet. – 2006. – V. 368. – P. 1444-1448.

10. Paolo Busardò F. Amniotic fluid embolism pathophysiology suggests the new diagnostic armamentarium: β-tryptase and complement fractions C3-C4 are the indispensable working tools /F. Paolo Busardò, P. Frati, S. Zaami //Int. J. Mol. Sci. – 2015. – V. 16. – P. 6557-6570.

11. Sultan P. Amniotic fluid embolism: update and review /P. Sultan, K. Seligman, B. Carvalho //Curr. Opin. Anaesthesiol. – 2016. – V. 29. – P. 288-296.

12. Tamura N. C1 esterase inhibitor activity in amniotic fluid embolism /N. Tamura, S. Kimura, M. Farhana //Crit. Care Med. – 2014. – V. 42. – P. 1392-1396.